Clifford Hudis

Clifford Hudis

UNVERIFIED PROFILE

Are you Clifford Hudis?   Register this Author

Register author
Clifford Hudis

Clifford Hudis

Publications by authors named "Clifford Hudis"

Are you Clifford Hudis?   Register this Author

100Publications

3651Reads

13Profile Views

Real transparency in medicine: Time to act.

Cancer 2019 Jul 29. Epub 2019 Jul 29.

National Comprehensive Cancer Network, Plymouth Meeting, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32407DOI Listing
July 2019

Copper-64 trastuzumab PET imaging: a reproducibility study.

Q J Nucl Med Mol Imaging 2019 Jun 12;63(2):191-198. Epub 2016 May 12.

Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S1824-4785.16.02867-3DOI Listing
June 2019

Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.

Clin Breast Cancer 2018 10 21;18(5):353-361. Epub 2017 Dec 21.

Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.12.009DOI Listing
October 2018

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.

Clin Breast Cancer 2018 10 15;18(5):387-394. Epub 2018 Mar 15.

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2018.03.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682312PMC
October 2018

Correlative imaging reveals physiochemical heterogeneity of microcalcifications in human breast carcinomas.

J Struct Biol 2018 04 6;202(1):25-34. Epub 2017 Dec 6.

Department of Materials Science and Engineering, Cornell University, Ithaca, NY 14853, USA; Kavli Institute at Cornell for Nanoscale Science, Cornell University, Ithaca, NY 14853, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsb.2017.12.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835408PMC
April 2018

The Impact of Obesity on Breast Cancer.

Curr Oncol Rep 2018 04 11;20(6):47. Epub 2018 Apr 11.

Memorial Sloan Kettering Cancer Center, 300 East 66th Street - 8th floor, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-018-0688-8DOI Listing
April 2018

Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impact.

Breast Cancer Res Treat 2018 01 6;167(2):547-554. Epub 2017 Oct 6.

Cedars-Sinai Medical Center, 8700 Beverly Blvd, AC 1042B, Los Angeles, CA, 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4520-1DOI Listing
January 2018

Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.

BMC Cancer 2018 01 6;18(1):42. Epub 2018 Jan 6.

Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3985-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756373PMC
January 2018

21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.

Breast Cancer Res Treat 2017 Nov 12;166(1):69-76. Epub 2017 Jul 12.

Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4381-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647226PMC
November 2017

Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.

Breast Cancer Res Treat 2017 Nov 14;166(1):241-247. Epub 2017 Jul 14.

Department of Medicine, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, Brooklyn, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4362-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647229PMC
November 2017

The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis.

Breast Cancer Res Treat 2017 Aug 3;165(1):65-76. Epub 2017 Jun 3.

Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4326-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572649PMC
August 2017

Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).

Breast Cancer Res Treat 2017 Jul 31;164(1):107-117. Epub 2017 Mar 31.

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4222-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479131PMC
July 2017

Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement.

J Clin Oncol 2017 Jun 30;35(16):1845-1854. Epub 2017 Mar 30.

Kala Visvanathan, Johns Hopkins Bloomberg School of Public Health and Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD; Laura A. Levit and Clifford A. Hudis, American Society of Clinical Oncology, Alexandria, VA; Derek Raghavan, Carolinas HealthCare System, Charlotte, NC; Sandra Wong, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Amylou Dueck, Mayo Clinic, Rochester, MN; and Gary H. Lyman, Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6414DOI Listing
June 2017

Reply to L.B. Marks et al.

J Clin Oncol 2017 04 9;35(11):1258-1259. Epub 2017 Jan 9.

Abram Recht, Beth Israel Deaconess Medical Center, Boston, MA; Elizabeth A. Comen, Memorial Sloan Kettering Cancer Center, New York, NY; Richard E. Fine, The West Clinic Comprehensive Breast Center, Germantown, TN; Gini F. Fleming, University of Chicago Medical Center, Chicago, IL; Patricia H. Hardenbergh, Shaw Regional Cancer Center, Edwards, CO; Alice Y. Ho, Memorial Sloan Kettering Cancer Center, New York, NY; Clifford A. Hudis, American Society of Clinical Oncology, Alexandria, VA; E. Shelley Hwang, Duke University Medical Center, Durham, NC; Jeffrey J. Kirshner, Hematology-Oncology Associates of Central New York, East Syracuse, NY; Monica Morrow, Memorial Sloan Kettering Cancer Center, New York, NY; Kilian E. Salerno, Roswell Park Cancer Institute, Buffalo, NY; George W. Sledge Jr, Stanford University Medical Center, Palo Alto, CA; Lawrence J. Solin, Albert Einstein Healthcare Network, Philadelphia, PA; Patricia A. Spears, North Carolina State University, Raleigh, NC; Timothy J. Whelan, McMaster University, Hamilton, Ontario, Canada; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; and Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3966DOI Listing
April 2017

The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials.

Eur J Cancer 2017 04 24;75:245-258. Epub 2017 Feb 24.

Department of Medical, Surgery and Health Sciences, University of Trieste, Piazza Ospitale 1, 34129 Trieste, Italy; Unit of Molecular Therapy and Pharmacogenomic, ASST Cremona, Viale Concordia 1, 26100 Cremona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.01.026DOI Listing
April 2017

Estimating the OncotypeDX score: validation of an inexpensive estimation tool.

Breast Cancer Res Treat 2017 02 7;161(3):435-441. Epub 2016 Dec 7.

Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-4069-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310948PMC
February 2017

Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527.

J Clin Oncol 2017 Feb 19;35(4):421-431. Epub 2016 Dec 19.

Rachel A. Freedman, Eric P. Winer, and Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Jared C. Foster, Drew K. Seisler, Jacqueline M. Lafky, and Aminah Jatoi, Mayo Clinic; Jared C. Foster and Drew K. Seisler, Mayo Cancer Center, Rochester, MN; Hyman B. Muss and Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Harvey J. Cohen, Constance Cirrincione, and Gretchen Kimmick, Duke University, Durham, NC; Jeanne Mandelblatt, Georgetown University, Washington, DC; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; Alvaro Moreno-Aspitia, Mayo Clinic, Jacksonville, FL; and Arti Hurria, City of Hope, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.4182DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455700PMC
February 2017

Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer.

Clin Breast Cancer 2016 12 1;16(6):487-493. Epub 2016 Aug 1.

Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2016.07.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575753PMC
December 2016

Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.

J Clin Oncol 2016 12 30;34(36):4431-4442. Epub 2016 Sep 30.

Abram Recht, Beth Israel Deaconess Medical Center, Boston, MA; Elizabeth A. Comen, Alice Y. Ho, Clifford A. Hudis, Monica Morrow, Memorial Sloan Kettering Cancer Center; New York; Jeffrey J. Kirshner, Hematology Oncology Associates of Central New York, East Syracuse; Kilian E. Salerno and Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY; Richard E. Fine, West Clinic Comprehensive Breast Center, Germantown, TN; Gini F. Fleming, University of Chicago Medical Center, Chicago, IL; Patricia H. Hardenbergh, Shaw Regional Cancer Center, Edwards, CO; E. Shelley Hwang, Duke University Medical Center, Durham; Patricia A. Spears, North Carolina State University, Raleigh, NC; George W. Sledge Jr, Stanford University Medical Center, Palo Alto, CA; Lawrence J. Solin, Albert Einstein Healthcare Network, Philadelphia, PA; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; and Timothy J. Whelan, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.1188DOI Listing
December 2016

Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation.

J Clin Oncol 2016 12 7;34(35):4270-4276. Epub 2016 Nov 7.

Neil M. Iyengar, Ayca Gucalp, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center; Neil M. Iyengar, Ayca Gucalp, Andrew J. Dannenberg, and Clifford A. Hudis, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.4283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562428PMC
December 2016

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance).

J Clin Oncol 2016 08 2;34(22):2602-9. Epub 2016 May 2.

Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.1595DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012690PMC
August 2016

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.

J Clin Oncol 2016 08 31;34(24):2925-34. Epub 2016 May 31.

Lowell E. Schnipper, Beth Israel Deaconess Medical Center, Harvard Medical School; Therese Mulvey and Jeffrey Peppercorn, Massachusetts General Hospital; Deborah Schrag, Dana-Farber Cancer Institute, Boston, MA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh; Adam P. Dicker, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA; Dana S. Wollins and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Douglas W. Blayney, Stanford University Medical Center, Stanford; Patricia A. Ganz, Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles; Peter P. Yu, Palo Alto Medical Foundation, Palo Alto, CA; J. Russell Hoverman, Texas Oncology, Dallas, TX; Robert Langdon, Nebraska Cancer Specialists; Julie M. Vose, University of Nebraska Medical Center, Omaha, NE; Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Neal J. Meropol, University Hospitals Case Medical Center Seidman Cancer Center, Case Comprehensive Cancer Center, and Case Western Reserve University, Cleveland, OH; Lee Newcomer, UnitedHealthcare, Minneapolis, MN; Blase Polite, University of Chicago Medicine, Chicago, IL; Derek Raghavan, Levine Cancer Institute, Charlotte, NC; Gregory Rossi, AstraZeneca, Macclesfield, United Kingdom; Leonard Saltz and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; and Thomas J. Smith, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.2518DOI Listing
August 2016

Increasing Precision in Adjuvant Therapy for Breast Cancer.

N Engl J Med 2016 Aug;375(8):790-1

From the American Society of Clinical Oncology, Alexandria, VA (C.A.H.); and the Breast Medicine Service, Memorial Sloan Kettering Cancer Center (C.A.H., M.D.), and Weill Cornell Medical College (M.D.) - both in New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1607947DOI Listing
August 2016

Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.

J Clin Oncol 2016 07 21;34(20):2359-65. Epub 2016 Mar 21.

Tari A. King, Jaclyn P. Lyman, Mithat Gonen, Amy Voci, Marina De Brot, Camilla Boafo, Larry Norton, Monica Morrow, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Amy Pratt Sing, Genomic Health, Redwood City; Michael D. Alvarado, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; E. Shelley Hwang, Duke University School of Medicine, Durham, NC; Minetta C. Liu, Georgetown University Medical Center, Washington, DC; Judy C. Boughey, Mayo Clinic, Rochester, MN; Kandace P. McGuire, University of Pittsburgh, Pittsburgh, PA; Catherine H. Van Poznak, University of Michigan Medical School, Ann Arbor, MI; Lisa K. Jacobs, Johns Hopkins University School of Medicine, Baltimore, MD; Ingrid M. Meszoely, Vanderbilt University Medical Center, Nashville, TN; Helen Krontiras, University of Alabama at Birmingham School of Medicine, Birmingham, AL; and Gildy V. Babiera, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1960DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981976PMC
July 2016

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

N Engl J Med 2016 Jul 5;375(3):209-19. Epub 2016 Jun 5.

From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston; the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.); Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada; Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.); University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.); University of Washington School of Medicine, Seattle (J.G.); Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.); Colorado Cancer Research Program, Denver (K.S.); Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.); Memorial Sloan Kettering Cancer Center, New York (C.H.); University of Arizona, Tucson (A.S.); and Highlands Oncology Group, Fayetteville, AR (J.T.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1604700DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024713PMC
July 2016

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression.

J Clin Oncol 2016 05 16;34(14):1689-701. Epub 2016 Feb 16.

Harold J. Burstein and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Christina Lacchetti, American Society of Clinical Oncology, Alexandria, VA; Holly Anderson, Breast Cancer Coalition of Rochester, Rochester, NY; Thomas A. Buchholz and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center, Houston, TX; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Karen E. Gelmon, British Columbia Cancer Agency, Vancouver, BC; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Alexander J. Solky, Interlakes Oncology and Hematology PC, Rochester, NY; Vered Stearns, Johns Hopkins, Baltimore, MD; and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.9573DOI Listing
May 2016

Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status.

Cancer 2016 Apr 9;122(8):1178-84. Epub 2016 Feb 9.

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29903DOI Listing
April 2016

Reply to L.A. Newman.

J Clin Oncol 2016 Mar 19;34(9):1015. Epub 2016 Jan 19.

Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.3808DOI Listing
March 2016

Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic review.

NPJ Breast Cancer 2016 30;2:16006. Epub 2016 Mar 30.

Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/npjbcancer.2016.6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515341PMC
March 2016

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.

J Clin Oncol 2016 Feb 2;34(6):542-9. Epub 2015 Nov 2.

Lisa A. Carey, David W. Ollila, Carey K. Anders, Katherine A. Hoadley, Michael Iglesia, and Charles M. Perou, University of North Carolina Chapel Hill, Chapel Hill; Constance T. Cirrincione and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Donald A. Berry, Alliance Statistics and Data Center, MD Anderson, Houston, TX; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Ian E. Krop and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Lyndsay N. Harris, University Hospitals of Cleveland, Cleveland, OH; Norah Lynn Henry, University of Michigan, Ann Arbor, MI; Douglas J. Weckstein, New Hampshire Hematology-Oncology, Hooksett, NH; Baljit Singh, New York University; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Maggie Chon U. Cheang, Clinical Trials and Statistics Unit, Institute of Cancer Research, Belmont, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.1268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980567PMC
February 2016

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

J Clin Oncol 2016 Feb 7;34(6):557-65. Epub 2015 Dec 7.

Ethan Basch, Mark G. Kris, Howard I. Scher, Clifford A. Hudis, Paul Sabbatini, Lauren Rogak, Thomas M. Atkinson, Joanne F. Chou, Dorothy Dulko, Laura Sit, Michael Fruscione, and Deborah Schrag, Memorial Sloan Kettering Cancer Center, New York, NY; Ethan Basch, Allison M. Deal, and Antonia V. Bennett, University of North Carolina, Chapel Hill, NC; Amylou C. Dueck, Mayo Clinic, Scottsdale, AZ; Allison Barz, Children's Hospital of Philadelphia, Philadelphia, PA; Paul Novotny and Jeff A. Sloan, Mayo Clinic, Rochester, MN; and Deborah Schrag, Dana-Farber/Harvard Cancer Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.0830DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872028PMC
February 2016

Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression.

Semin Oncol 2016 Feb 8;43(1):154-160. Epub 2015 Sep 8.

Department of Medicine, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2015.09.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789163PMC
February 2016

Response.

J Natl Cancer Inst 2016 Jan;108(1)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv334DOI Listing
January 2016

Adjuvant hormonal therapy in premenopausal women with breast cancer.

Indian J Med Paediatr Oncol 2015 Oct-Dec;36(4):195-200

Breast Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0971-5851.171530DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711215PMC
January 2016

NCCN Guidelines Insights Breast Cancer, Version 1.2016.

J Natl Compr Canc Netw 2015 Dec;13(12):1475-85

From Robert H. Lurie Comprehensive Cancer Center of Northwestern University; University of Washington/Seattle Cancer Care Alliance; UCSF Helen Diller Family Comprehensive Cancer Center; UC San Diego Moores Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; University of Colorado Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; University of Alabama at Birmingham Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Mayo Clinic Cancer Center; Fox Chase Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital Cancer Center; Duke Cancer Institute; Vanderbilt-Ingram Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center; Roswell Park Cancer Institute; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Research Advocacy Network; Moffitt Cancer Center; City of Hope Comprehensive Cancer Center; Stanford Cancer Institute; Huntsman Cancer Institute at the University of Utah; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0176DOI Listing
December 2015

Obesity and Cancer: Concepts and Challenges.

Indian J Surg Oncol 2015 Dec 23;6(4):390-8. Epub 2015 Nov 23.

Memorial Sloan Kettering Cancer Center, 300 East 66th Street - 8th floor, New York, NY 10065 USA ; Weill Cornell Medical College, New York, NY USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13193-015-0483-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809858PMC
December 2015

Erratum to: Obesity and Cancer: Concepts and Challenges.

Indian J Surg Oncol 2015 Dec 22;6(4):399. Epub 2015 Dec 22.

Memorial Sloan Kettering Cancer Center, 300 East 66th Street - 8th floor, New York, NY 10065 USA ; Weill Cornell Medical College, New York, NY USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13193-015-0484-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809843PMC
December 2015

Big data: Are large prospective randomized trials obsolete in the future?

Authors:
Clifford A Hudis

Breast 2015 Nov;24 Suppl 2:S15-8

Memorial Sloan Kettering Cancer Center, United States; Weill Cornell Medical College, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2015.07.005DOI Listing
November 2015

Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement.

J Clin Oncol 2015 Nov 31;33(33):3961-7. Epub 2015 Aug 31.

Jennifer A. Ligibel and Elizabeth S. Frank, Dana-Farber Cancer Institute, Boston, MA; Catherine M. Alfano, Elvan C. Daniels, and Kevin D. Stein, American Cancer Society, Atlanta, GA; Dawn Hershman, Columbia University; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Rachel M. Ballard, National Institutes of Health; Worta McCaskill-Stevens and Lori M. Minasian, National Cancer Institute, Bethesda, MD; Suanna S. Bruinooge and Laura A. Levit, American Society of Clinical Oncology, Alexandria, VA; Kerry S. Courneya, University of Alberta, Edmonton, Alberta; Pamela J. Goodwin, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada; Wendy Demark-Wahnefried, University of Alabama at Birmingham, Birmingham, AL; Melinda L. Irwin, Yale School of Public Health, New Haven, CT; Mark A. O'Rourke, Greenville Hospital System, Greenville, SC; John P. Pierce, University of California San Diego Moores Cancer Center, San Diego, CA; and Cynthia A. Thomson, University of Arizona, Tucson, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1440DOI Listing
November 2015

Biology before Anatomy in Early Breast Cancer--Precisely the Point.

Authors:
Clifford A Hudis

N Engl J Med 2015 Nov 27;373(21):2079-80. Epub 2015 Sep 27.

From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College - both in New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1512092DOI Listing
November 2015

Neoadjuvant Therapy in Breast Cancer as a Basis for Drug Approval.

JAMA Oncol 2015 Oct;1(7):875-6

Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.1293DOI Listing
October 2015

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance).

J Natl Cancer Inst 2015 Sep 25;107(9). Epub 2015 Jun 25.

Dana-Farber Cancer Institute, Boston, MA (JAL, EW); Alliance Statistics and Data Center, Durham, NC (CTC); Mayo Clinic, Rochester, MN (ML, JNI); Hofstra North Shore - LIJ School of Medicine, ProHEALTH Care Associates, Lake Success, NY (MC); Northwestern University Feinberg School of Medicine, Chicago, IL (WG); The Angeles Clinic and Research Institute, Santa Monica, CA (SM); Rhode Island Hospital, Providence, RI (WS); St. Barnabas Medical Center, Livingston, NJ (RM); The Genome Institute, Washington University in St. Louis, St. Louis, MO (EM); Department of Genetics, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC (CMP); Breast Cancer Program, Siteman Cancer Center and Washington University School of Medicine, St. Louis, MO (ME); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX (DB); Alliance Statistics and Data Center, Dana-Farber Cancer Institute, Boston, MA (WTB).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/107/9/djv179.full.pdf
Web Search
http://dx.doi.org/10.1093/jnci/djv179DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651106PMC
September 2015

Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance).

Ann Surg 2015 Sep;262(3):434-9; discussion 438-9

*Department of Surgery, Brigham and Women's Hospital, Boston, MA †Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC ‡Department of Medical Oncology Women and Infants Hospital and Alpert Medical School of Brown University, Providence, RI §Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX ¶Department of Medical Oncology, Maine Center for Cancer Medicine, Scarborough, ME ∥Department of Medical Oncology, City of Hope Medical Center, Los Angeles, CA **Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY ††Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and ‡‡Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710511PMC
September 2015

Parsing Progress in Breast Cancer.

J Clin Oncol 2015 Sep 10;33(26):2837-8. Epub 2015 Aug 10.

Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.4890DOI Listing
September 2015

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.

J Clin Oncol 2015 Aug 22;33(23):2563-77. Epub 2015 Jun 22.

Lowell E. Schnipper, Beth Israel Deaconess Medical Center, Harvard Medical School; Jeffrey Peppercorn, Massachusetts General Hospital; Deborah Schrag, Dana-Farber Cancer Institute, Boston; Therese Mulvey, Southcoast Centers for Cancer Care, Fall River, MA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh; Adam P. Dicker, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA; Dana S. Wollins, Courtney Tyne, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Douglas W. Blayney, Stanford University Medical Center, Stanford; Patricia A. Ganz, Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles; Peter P. Yu, Palo Alto Medical Foundation, Palo Alto, CA; Diane Blum, National Executive Service Corps; Leonard Saltz and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; J. Russell Hoverman, Texas Oncology, Dallas, TX; Robert Langdon, Nebraska Cancer Specialists, Omaha, NE; Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Neal J. Meropol, University Hospitals Case Medical Center Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH; Lee Newcomer, UnitedHealthcare, Minneapolis, MN; Blase Polite, University of Chicago Medicine, Chicago, IL; Derek Raghavan, Levine Cancer Institute, Charlotte, NC; Gregory Rossi, AstraZeneca, Macclesfield, Cheshire, United Kingdom; and Thomas J. Smith, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.61.6706
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.61.6706DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015427PMC
August 2015

Obesity and Breast Cancer: Narrowing the Focus.

JAMA Oncol 2015 Aug;1(5):622-3

Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.1547DOI Listing
August 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015